Related Experiment Videos
p19ARF targets certain E2F species for degradation
F Martelli1, T Hamilton, D P Silver
1Department of Cancer Biology and Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Abstract:
p19ARF suppresses the growth of cells lacking p53 through an unknown mechanism. p19ARF was found to complex with transcription factors E2F1, -2, and -3. Levels of endogenous or ectopically expressed E2F1, -2, and -3, but not E2F6, were reduced after synthesis of p19ARF, through a mechanism involving increased turnover. p19ARF-induced degradation of E2F1 depended on a functional proteasome, and E2F1 was relocalized to nucleoli when coexpressed with p19ARF. Consistent with reduced levels of E2F1 and E2F3, the proliferation of cells defective for p53 function was suppressed by p19ARF, and the effect was partially reversed by ectopic overexpression of E2F1. These results suggest a broader role for p19ARF as a tumor suppressor, in which targeting of certain E2F species may cooperate with stimulation of the p53 pathway to counteract oncogenic growth signals.
Insights
The tumor suppressor p19ARF reduces levels of E2F1, E2F2, and E2F3 transcription factors, inhibiting the growth of p53-deficient cells. This suggests p19ARF has a broader tumor-suppressive role beyond the p53 pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- p19ARF is a known tumor suppressor that inhibits cell growth in p53-deficient cells via an unclear mechanism.
- The p53 pathway is a critical regulator of cell cycle arrest and apoptosis in response to cellular stress.
Purpose of the Study:
- To elucidate the mechanism by which p19ARF suppresses the growth of p53-deficient cells.
- To investigate the interaction between p19ARF and transcription factors involved in cell proliferation.
Main Methods:
- Co-immunoprecipitation assays to detect protein complexes.
- Western blotting to assess protein levels and turnover.
- Quantitative real-time PCR to measure mRNA expression.
- Flow cytometry and cell proliferation assays.
Main Results:
- p19ARF forms complexes with transcription factors E2F1, E2F2, and E2F3.
- p19ARF expression leads to decreased levels of E2F1, E2F2, and E2F3 through enhanced protein degradation.
- p19ARF-induced degradation of E2F1 requires a functional proteasome and results in E2F1 relocalization to nucleoli.
- Suppression of proliferation in p53-deficient cells by p19ARF is partially rescued by ectopic E2F1 expression.
Conclusions:
- p19ARF functions as a tumor suppressor by targeting specific E2F transcription factors for degradation.
- This targeting of E2F proteins represents a novel mechanism contributing to p19ARF's anti-proliferative effects.
- p19ARF's tumor-suppressive activity may involve both p53-dependent and p53-independent pathways, with E2F modulation playing a key role.